Skip to main content
Journal cover image

High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancer.

Publication ,  Journal Article
Shpall, EJ; Clarke-Pearson, D; Soper, JT; Berchuck, A; Jones, RB; Bast, RC; Ross, M; Lidor, Y; Vanacek, K; Tyler, T
Published in: Gynecol Oncol
September 1990

Duke Scholars

Published In

Gynecol Oncol

DOI

ISSN

0090-8258

Publication Date

September 1990

Volume

38

Issue

3

Start / End Page

386 / 391

Location

United States

Related Subject Headings

  • Transplantation, Autologous
  • Thiotepa
  • Ovarian Neoplasms
  • Oncology & Carcinogenesis
  • Middle Aged
  • Humans
  • Female
  • Cyclophosphamide
  • Combined Modality Therapy
  • Cisplatin
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Shpall, E. J., Clarke-Pearson, D., Soper, J. T., Berchuck, A., Jones, R. B., Bast, R. C., … Tyler, T. (1990). High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancer. Gynecol Oncol, 38(3), 386–391. https://doi.org/10.1016/0090-8258(90)90079-z
Shpall, E. J., D. Clarke-Pearson, J. T. Soper, A. Berchuck, R. B. Jones, R. C. Bast, M. Ross, Y. Lidor, K. Vanacek, and T. Tyler. “High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancer.Gynecol Oncol 38, no. 3 (September 1990): 386–91. https://doi.org/10.1016/0090-8258(90)90079-z.
Shpall EJ, Clarke-Pearson D, Soper JT, Berchuck A, Jones RB, Bast RC, et al. High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancer. Gynecol Oncol. 1990 Sep;38(3):386–91.
Shpall, E. J., et al. “High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancer.Gynecol Oncol, vol. 38, no. 3, Sept. 1990, pp. 386–91. Pubmed, doi:10.1016/0090-8258(90)90079-z.
Shpall EJ, Clarke-Pearson D, Soper JT, Berchuck A, Jones RB, Bast RC, Ross M, Lidor Y, Vanacek K, Tyler T. High-dose alkylating agent chemotherapy with autologous bone marrow support in patients with stage III/IV epithelial ovarian cancer. Gynecol Oncol. 1990 Sep;38(3):386–391.
Journal cover image

Published In

Gynecol Oncol

DOI

ISSN

0090-8258

Publication Date

September 1990

Volume

38

Issue

3

Start / End Page

386 / 391

Location

United States

Related Subject Headings

  • Transplantation, Autologous
  • Thiotepa
  • Ovarian Neoplasms
  • Oncology & Carcinogenesis
  • Middle Aged
  • Humans
  • Female
  • Cyclophosphamide
  • Combined Modality Therapy
  • Cisplatin